177 related articles for article (PubMed ID: 9690968)
1. Early detection and intervention in schizophrenia.
Linszen DH; Dingemans PM; Lenior ME; Scholte WF; de Haan L; Goldstein MJ
Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S31-4. PubMed ID: 9690968
[TBL] [Abstract][Full Text] [Related]
2. Good medical practice in antipsychotic pharmacotherapy.
Peuskens J
Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S35-41. PubMed ID: 9690969
[TBL] [Abstract][Full Text] [Related]
3. Relapse prevention in schizophrenia - new therapeutic challenges.
Kucukalić A; Dzubur-Kulenović A; Mehmedika-Suljić E
Psychiatr Danub; 2007 Dec; 19(4):362-6. PubMed ID: 18000490
[TBL] [Abstract][Full Text] [Related]
4. [Longterm treatment of schizophrenia].
Pajonk VF
MMW Fortschr Med; 2006 Jan; 148(4):35-8. PubMed ID: 16502798
[TBL] [Abstract][Full Text] [Related]
5. Relapse prevention and recovery in the treatment of schizophrenia.
Schooler NR
J Clin Psychiatry; 2006; 67 Suppl 5():19-23. PubMed ID: 16822093
[TBL] [Abstract][Full Text] [Related]
6. Management of treatment refractory schizophrenia.
Morrison DP
Br J Psychiatry Suppl; 1996 Dec; (31):15-20. PubMed ID: 8968651
[No Abstract] [Full Text] [Related]
7. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders.
Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for the Treatment of Schizophrenia and Related Disorders
Aust N Z J Psychiatry; 2005; 39(1-2):1-30. PubMed ID: 15660702
[TBL] [Abstract][Full Text] [Related]
8. The use of electroconvulsive therapy in a cohort of forensic psychiatric patients with schizophrenia.
Kristensen D; Brandt-Christensen M; Ockelmann HH; Jørgensen MB
Crim Behav Ment Health; 2012 Apr; 22(2):148-56. PubMed ID: 22124975
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia: Evidence From a Community-Based "Real-World" Study.
Zhang C; Chen MJ; Wu GJ; Wang ZW; Rao SZ; Zhang Y; Yi ZH; Yang WM; Gao KM; Song LS
J Clin Psychiatry; 2016 Nov; 77(11):e1460-e1466. PubMed ID: 28076667
[TBL] [Abstract][Full Text] [Related]
10. Treatment adherence and insight in schizophrenia.
Bitter I; Fehér L; Tényi T; Czobor P
Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
[TBL] [Abstract][Full Text] [Related]
11. Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention.
Francey SM; Nelson B; Thompson A; Parker AG; Kerr M; Macneil C; Fraser R; Hughes F; Crisp K; Harrigan S; Wood SJ; Berk M; McGorry PD
Schizophr Res; 2010 Jun; 119(1-3):1-10. PubMed ID: 20347270
[TBL] [Abstract][Full Text] [Related]
12. [Suicidal risk during the first psychotic episode].
Courtet P
Encephale; 2018 Dec; 44(6S):S39-S43. PubMed ID: 30935486
[TBL] [Abstract][Full Text] [Related]
13. [Detection of early warning signs in schizophrenic patients. Possible applications in prevention of recurrence].
Wiedemann G; Hahlweg K; Hank G; Feinstein E; Müller U; Dose M
Nervenarzt; 1994 Jul; 65(7):438-43. PubMed ID: 7800087
[TBL] [Abstract][Full Text] [Related]
14. TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial.
Stürup AE; Jensen HD; Dolmer S; Birk M; Albert N; Nielsen M; Hjorthøj C; Eplov L; Ebdrup BH; Mors O; Nordentoft M
Trials; 2017 Sep; 18(1):445. PubMed ID: 28962668
[TBL] [Abstract][Full Text] [Related]
15. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
[TBL] [Abstract][Full Text] [Related]
16. Critical issues in the treatment of schizophrenia.
Gaebel W
Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S1-6. PubMed ID: 9690963
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia.
Leucht S; Heres S
J Clin Psychiatry; 2006; 67 Suppl 5():3-8. PubMed ID: 16822090
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of acute and chronic psychoses in childhood and adolescence].
Eggers Ch
MMW Fortschr Med; 2005 Dec; 147(48):41, 43-5. PubMed ID: 16389861
[TBL] [Abstract][Full Text] [Related]
19. Management of schizophrenia.
Marder SR
J Clin Psychiatry; 1996; 57 Suppl 3():9-13; discussion 47. PubMed ID: 8626371
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting outcome in schizophrenia and their relevance for psychopharmacological treatment.
Altamura AC; Bobo WV; Meltzer HY
Int Clin Psychopharmacol; 2007 Sep; 22(5):249-67. PubMed ID: 17690594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
